Global Procurement News
  Global Tenders - Procurement News, Plans & Forecast from Pharmaceuticals
Global Procurement News - Business Opportunities - International Procurement News
Procurement News - Procurement News provides business development opportunities from the private and public sector, subcontracting opportunities in the form of contract award news, a way to keep you updated all the time. It keeps updated with all the changes in your industry.

Below are the procurement news, procurement plan and procurement forecast from - Pharmaceuticals
564 Record Matches Your Request
Showing 1 - 10 Records
Tender Notice Type: Procurement Forecast Country : Bangladesh
Tender Category: Pharmaceuticals
Description: Procurement Of Vitamin A Plus Campaign Material
Action Deadline: 21 Nov 2017 Ref. no.: 429937258
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United Kingdom
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Pharmaceuticals
Description: United Kingdom : Mallinckrodt plc Presents Health Economic Data on OFIRMEV® (acetaminophen) Injection at ASRA 16th Annual Pain Medicine Meeting
Action Deadline:   Ref. no.: 429931495
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United States
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Pharmaceuticals
Description: United States : Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen
Action Deadline:   Ref. no.: 429931370
View Tender Details: View Details
Tender Notice Type: Procurement News Country : Australia
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Industry , Pharmaceuticals
Description: Australia : New 6CPA resource hub for all pharmacists
Action Deadline:   Ref. no.: 429925888
View Tender Details: View Details
Tender Notice Type: Procurement News Country : Japan
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: Japan : Chugai’s Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase III Study - emicizumab prophylaxis shown to reduce bleeding in patients without inhibitors
Action Deadline:   Ref. no.: 429925387
View Tender Details: View Details
Tender Notice Type: Procurement News Country : India
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: India : Biocon's Drug product Facility Receives EIR with VAI status, Inspection Closed
Action Deadline:   Ref. no.: 429925375
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United States
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: United States : Genentech’s Hemlibra (Emicizumab-kxwh) Significantly Reduced Bleeds in Phase III Study in Hemophilia A
Action Deadline:   Ref. no.: 429925318
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United States
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: United States : Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the I
Action Deadline:   Ref. no.: 429925317
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United States
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: United States : Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial
Action Deadline:   Ref. no.: 429925303
View Tender Details: View Details
Tender Notice Type: Procurement News Country : United States
Tender Category: Banking, Finance, Insurance and Securities (BFIS) , Healthcare and Medicine , Pharmaceuticals
Description: United States : Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma
Action Deadline:   Ref. no.: 429925281
View Tender Details: View Details
Next Page
Global Tenders has one of the largest database of international and national tenders/competitive bids, procurement news, project information, contract awards, related to Pharmaceuticals sector from all over the world..

This section contains procurement news, procurement plan and procurement forecast from Pharmaceuticals sector.
Global Tenders World Tenders International Tenders Copyright 2002-2017 Anroh Global Services Pvt. Ltd./World Information Pages/Global Tenders. All rights reserved.